Patents by Inventor Jinling Lv

Jinling Lv has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8349835
    Abstract: The invention belongs to pharmaceutical field. The invention relates to the compounds according to Formula I, including their optically active forms, pharmaceutically acceptable salts or hydrates, and the pharmaceutical composition comprising thereof as active ingredient; uses in the preparation of vascular endothelial growth factor receptor tyrosine kinase inhibitors, and uses in the preparation of medicament for the treatment and/or prevention of cancer.
    Type: Grant
    Filed: February 10, 2009
    Date of Patent: January 8, 2013
    Assignee: Shenyang Pharmaceutical University
    Inventors: Linxiang Zhao, Jinling Lv, Rui Wang, Dan Liu, Yongkui Jing
  • Publication number: 20110183972
    Abstract: The invention belongs to pharmaceutical field. The invention relates to the compounds according to Formula I, including their optically active forms, pharmaceutically acceptable salts or hydrates, and the pharmaceutical composition comprising thereof as active ingredient; uses in the preparation of vascular endothelial growth factor receptor tyrosine kinase inhibitors, and uses in the preparation of medicament for the treatment and/or prevention of cancer.
    Type: Application
    Filed: February 10, 2009
    Publication date: July 28, 2011
    Applicant: SHENYANG PHARMACEUTICAL UNIVERSITY
    Inventors: Linxiang Zhao, Jinling Lv, Rui Wang, Dan Liu, Yongkui Jing